{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:34:10Z","timestamp":1788878050699,"version":"build-2803163510"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2301800"],"award-info":[{"award-number":["2021YFC2301800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ijantimicag.2023.106875","type":"journal-article","created":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T19:13:26Z","timestamp":1685819606000},"page":"106875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Concentration of contezolid in cerebrospinal fluid and serum in a patient with tuberculous meningoencephalitis: A case report"],"prefix":"10.1016","volume":"62","author":[{"given":"Wanru","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwan","family":"Shangguan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2023.106875_bib0001","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TNMI7-0044-2017","article-title":"Central nervous system tuberculosis","volume":"5","author":"Leonard","year":"2017","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2023.106875_bib0002","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1128\/AAC.02784-14","article-title":"Linezolid manifests a rapid and dramatic therapeutic effect for patients with life-threatening tuberculous meningitis","volume":"58","author":"Sun","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106875_bib0003","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1183\/09031936.00022912","article-title":"Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis","volume":"40","author":"Sotgiu","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2023.106875_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2019.04.025","article-title":"Tolerability and pharmacokinetics of contezolid at therapeutic and supratherapeutic doses in healthy Chinese subjects, and assessment of contezolid dosing regimens based on pharmacokinetic\/pharmacodynamic analysis","volume":"41","author":"Wu","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2023.106875_bib0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5582\/ddt.2022.01025","article-title":"Prospects of contezolid (MRX-I) against multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis","volume":"16","author":"Yang","year":"2022","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.ijantimicag.2023.106875_bib0006","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41576-019-0113-7","article-title":"Clinical metagenomics","volume":"20","author":"Chiu","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ijantimicag.2023.106875_bib0007","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1515\/cclm-2016-0700","article-title":"The use of liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of antibiotics in cancer patients","volume":"55","author":"El-Najjar","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ijantimicag.2023.106875_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00493-18","article-title":"In vitro and in vivo activities of contezolid (MRX-I) against Mycobacterium tuberculosis","volume":"62","author":"Shoen","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106875_bib0009","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1021\/acs.chemrestox.0c00524","article-title":"Nonclinical evaluation of antibacterial oxazolidinones contezolid and contezolid acefosamil with low serotonergic neurotoxicity","volume":"34","author":"Wang","year":"2021","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.ijantimicag.2023.106875_bib0010","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1021\/jm401931e","article-title":"New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile","volume":"57","author":"Gordeev","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2023.106875_bib0011","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/ph16010032","article-title":"Development and validation of an LC-MS\/MS method for the quantitative determination of contezolid in human plasma and cerebrospinal fluid","volume":"16","author":"Zhang","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijantimicag.2023.106875_bib0012","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s40265-021-01576-0","article-title":"Contezolid: first approval","volume":"81","author":"Hoy","year":"2021","journal-title":"Drugs"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923001541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923001541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:47:16Z","timestamp":1760377636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857923001541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0924857923001541"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106875","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concentration of contezolid in cerebrospinal fluid and serum in a patient with tuberculous meningoencephalitis: A case report","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106875"}}